Children: Centers for Disease Control and Prevention classification, 1994
The Centers for Disease Control and Prevention (CDC) classify HIV-infected children either according to their immunological status (using CD4 cell counts and percentages) or their clinical status (based on physical health and symptoms)[1].
Immunological categories
Very young children normally have much higher CD4 counts than adults. The classification system for HIV-positive based on their CD4 levels therefore takes account of the child's age.
Children aged less than twelve months
Children are assigned to:
- Category 1 (no immunosuppression): CD4 cell count greater than 1499 cells/mm3 or CD4 percentage greater than 25%.
- Category 2 (moderate immunosuppression): CD4 cell count between 740 and 1499 cells/mm3 or CD4 percentage between 15 and 24%.
- Category 3 (severe immunosuppression): CD4 cell count below 750 cells/mm3 or CD4 percentage below 15%.
Children aged one to five years
Children are assigned to:
- Category 1 (no immunosuppression): CD4 cell count greater than 999 cells/mm3 or CD4 percentage greater than 25%.
- Category 2 (moderate immunosuppression): CD4 cell count between 500 and 999 cells/mm3 or CD4 percentage between 15 and 24%.
- Category 3 (severe immunosuppression): CD4 cell count below 500 cells/mm3 or CD4 percentage below 15%.
Children aged six to twelve years
Children are assigned to:
- Category 1 (no immunosuppression): CD4 cell count greater than 500 cells/mm3 or CD4 percentage greater than 25%.
- Category 2 (moderate immunosuppression): CD4 cell count between 200 and 499 cells/mm3 or CD4 percentage between 15 and 24%.
- Category 3 (severe immunosuppression): CD4 cell count below 200 cells/mm3 or CD4 percentage below 15%.
Clinical categories
Children are assigned to:
- Category N (not symptomatic): no signs or symptoms considered to be the result of HIV infection or only one of the conditions listed in Category A.
- Category A (mildly symptomatic): two or more of the conditions listed below but none of the conditions listed in Categories B and C.
- Lymphadenopathy larger than 0.5 cm at more than two sites.
- Hepatomegaly.
- Splenomegaly.
- Dermatitis.
- Parotitis.
- Recurrent or persistent upper respiratory infection, sinusitis or otitis media.
- Category B (moderately symptomatic): symptomatic conditions other than those listed for Category A or C that are attributed to HIV infection. Examples of conditions in clinical Category B include but are not limited to:
- Anaemia, neutropenia or thrombocytopenia persisting for longer than 30 days.
- Bacterial meningitis, pneumonia, or sepsis.
- Persistent oropharyngeal candidiasis in children less than six months of age.
- Cardiomyopathy.
- Cytomegalovirus infection, with onset before one month of age.
- Diarrhoea, recurrent or chronic.
- Hepatitis.
- Recurrent herpes simplex virus stomatitis.
- Herpes simplex virus bronchitis, pneumonitis, or oesophagitis with onset before one month of age.
- Herpes zoster involving at least two distinct episodes or more than one skin area.
- Leiomyosarcoma.
- Lymphoid interstitial pneumonia or pulmonary lymphoid hyperplasia complex.
- Nephropathy.
- Nocardiosis.
- Persistent fever lasting longer than one month.
- Toxoplasmosis, onset before one month of age.
- Disseminated varicella.
- Category C (severely symptomatic): any condition listed in the 1987 surveillance case definition for AIDS, with the exception of lymphoid interstitial pneumonia.
latest aidsmap news
- US Health Department identifies further 18 effective HIV prevention programmes
- More African people acquiring HIV in the UK than previously thought
- HIV prevalence may decline because the most vulnerable are infected and die first
- Lack of perceived need for HIV treatment associated with poor adherence
- TB doesn't always increase HIV viral load
- New 75mg darunavir tablet approved by FDA for use by HIV-positive children
- Thyroid checks recommended for people with HIV
- Knighthood for head of UK HIV charity
- Gay men often not accessing PEP despite risk of HIV exposure
- Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
